Showing 1 - 13 results of 13 for search 'Olav Dahl', query time: 0.06s
Refine Results
-
1
-
2
Stage-dependent prognostic shift in mismatch repair-deficient tumors: Assessing patient outcomes in stage II and III colon cancer by Kjersti Elvestad Hestetun, Kjersti Elvestad Hestetun, Nina Benedikte Rosenlund, Luka Stanisavljević, Olav Dahl, Olav Dahl, Mette Pernille Myklebust, Mette Pernille Myklebust
Published 2022-08-01
Article -
3
Serum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fa... by Sigrid Lunde, Einar K Kristoffersen, Dipak Sapkota, Kristin Risa, Olav Dahl, Ove Bruland, Olav Mella, Øystein Fluge
Published 2016-01-01
Article -
4
-
5
-
6
Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study. by Øystein Fluge, Ove Bruland, Kristin Risa, Anette Storstein, Einar K Kristoffersen, Dipak Sapkota, Halvor Næss, Olav Dahl, Harald Nyland, Olav Mella
Published 2011-01-01
Article -
7
Long-Term Outcome in a Phase II Study of Regional Hyperthermia Added to Preoperative Radiochemotherapy in Locally Advanced and Recurrent Rectal Adenocarcinomas by Baard-Christian Schem, Frank Pfeffer, Martin Anton Ott, Johan N. Wiig, Nils Sletteskog, Torbjørn Frøystein, Mette Pernille Myklebust, Sabine Leh, Olav Dahl, Olav Mella
Published 2022-01-01
Article -
8
B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment. by Øystein Fluge, Kristin Risa, Sigrid Lunde, Kine Alme, Ingrid Gurvin Rekeland, Dipak Sapkota, Einar Kleboe Kristoffersen, Kari Sørland, Ove Bruland, Olav Dahl, Olav Mella
Published 2015-01-01
Article -
9
Brainstem NTCP and Dose Constraints for Carbon Ion RT—Application and Translation From Japanese to European RBE-Weighted Dose by Jon Espen Dale, Jon Espen Dale, Silvia Molinelli, Barbara Vischioni, Viviana Vitolo, Maria Bonora, Giuseppe Magro, Andrea Mairani, Andrea Mairani, Azusa Hasegawa, Azusa Hasegawa, Tatsuya Ohno, Olav Dahl, Francesca Valvo, Piero Fossati, Piero Fossati
Published 2020-11-01
Article -
10
Spatial Agreement of Brainstem Dose Distributions Depending on Biological Model in Proton Therapy for Pediatric Brain Tumors by Lars Fredrik Fjæra, MSc, Daniel J. Indelicato, MD, Kristian S. Ytre-Hauge, PhD, Ludvig P. Muren, PhD, Yasmin Lassen-Ramshad, MD, Laura Toussaint, PhD, Olav Dahl, MD, Camilla H. Stokkevåg, PhD
Published 2021-01-01
Article -
11
Risk of carotid blowout after reirradiation with particle therapy by Jon Espen Dale, MD, Silvia Molinelli, MSc, Elisa Ciurlia, MD, Mario Ciocca, MSc, Maria Bonora, MD, Viviana Vitolo, MD, Alfredo Mirandola, MSc, Stefania Russo, MSc, Roberto Orecchia, MD, Olav Dahl, PhD, MD, Piero Fossati, MD
Published 2017-07-01
Article -
12
Blocking Aerobic Glycolysis by Targeting Pyruvate Dehydrogenase Kinase in Combination with EGFR TKI and Ionizing Radiation Increases Therapeutic Effect in Non-Small Cell Lung Cance... by Sissel E. Dyrstad, Maria L. Lotsberg, Tuan Zea Tan, Ina K. N. Pettersen, Silje Hjellbrekke, Deusdedit Tusubira, Agnete S. T. Engelsen, Thomas Daubon, Arnaud Mourier, Jean Paul Thiery, Olav Dahl, James B. Lorens, Karl Johan Tronstad, Gro V. Røsland
Published 2021-02-01
Article -
13
A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome by Fredrik Hoel, August Hoel, Ina K.N. Pettersen, Ingrid G. Rekeland, Kristin Risa, Kine Alme, Kari Sørland, Alexander Fosså, Katarina Lien, Ingrid Herder, Hanne L. Thürmer, Merete E. Gotaas, Christoph Schäfer, Rolf K. Berge, Kristian Sommerfelt, Hans-Peter Marti, Olav Dahl, Olav Mella, Øystein Fluge, Karl J. Tronstad
Published 2021-08-01
Article